Almirall, BioFocus enter three-year drug discovery alliance
Spain’s Almirall has consolidated its existing relationship with BioFocus, the UK-based drug discovery specialist and Galapagos affiliate, by announcing a three-year research alliance aimed at delivering “drug development candidates directed to a key respiratory target of interest to Almirall”. The collaboration could be worth as much as €7.5 million to BioFocus, which will apply its